Drug companies are abandoning antibiotic research to make more money elsewhere. Yet another reason why we need a publicly owned company.
Dana Brown
Dana Brown is deputy director of The Next System Project at the Democracy Collaborative.
Dana Brown is deputy director of The Next System Project at the Democracy Collaborative.
Drug companies are abandoning antibiotic research to make more money elsewhere. Yet another reason why we need a publicly owned company.
The Prospect runs on readers
No paywall, no corporate owners. Everything you read here is paid for by people like you. Chip in to keep it that way.
Cut through the noise of daily news with in-depth, progressive analysis.
Unsubscribe anytime. Submitting your email signs you up for our daily and weekly newsletters.
Cut through the noise of daily news with in-depth, progressive analysis.
Unsubscribe anytime. Submitting your email signs you up for our daily and weekly newsletters.
We'll create a new account for .